日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
World / US and Canada

Chinese biopharmaceutical company debuts on Nasdaq

By HENG WEILI in New York (China Daily USA) Updated: 2016-03-18 10:01

Hutchison ChinaMediTech Ltd, a Hong Kong-based biopharmaceutical company, started trading on Thursday on the Nasdaq Stock Market in New York.

Chi-Med, as the company is also known, tradeson Nasdaq under the symbol HCM. Shares closed at $13.40 on Thursday, 10 cents below their initial public offering price, after reaching an intraday high of $14.68.

In the IPO, which priced on Thursday morning, Chi-Med sold 7.5 million American depositary shares, raising $101.25 million. Bank of America, Merrill Lynch and Deutsche Bank Securities were the lead underwriters.

The company, which is majority owned by the multinational conglomerate CK Hutchison Holdings Ltd,calls itself a "globally-focused healthcare group which researches, develops, manufactures and sells pharmaceuticals and health-related consumer products".

Its innovation platform is focused on discovering and developing therapeutics in oncology and autoimmune diseases. The commercial platform manufactures, markets and distributes prescription drugs and consumer health products in China.

More specifically, Chi-Med is a developer of targeted, small molecule kinase (enzyme) inhibitors to treat a range of solid tumors, blood cancers and immune diseases. The company is conducting 20 active clinical trials in various countries, including two late-stage studies with AstraZeneca in the US and Eli Lilly in China, working toward potential new drug applications.

"Today is an important milestone for Chi-Med as we go public in the US market," said Simon To, executive director and chairman, who along with CEO Christian Hoggrang the Nasdaq closing bell on Thursday.

"Our R&D is focused on addressing the shortcomings of many of the currently approved kinase inhibitors, specifically the off-target toxicities that limit drug exposure and efficacy," To said. "We hope our efforts will result in life-saving therapies for the many patients around the world with few or no treatment options."

"We welcome Chi-Med as they continue to advance their rapidly growing pipeline," said Bob McCooey, who is the senior vice-president for listing services at Nasdaq. "As the venue of choice for innovators and visionaries around the globe, we are excited to be the strategic partner that supports revolutionary companies as they take on the world stage."

hengweili@chinadailyusa.com

Trudeau visits Sina Weibo
May gets little gasp as EU extends deadline for sufficient progress in Brexit talks
Ethiopian FM urges strengthened Ethiopia-China ties
Yemen's ex-president Saleh, relatives killed by Houthis
Most Popular
Hot Topics

...
主站蜘蛛池模板: 97色在线观看 | 狠狠综合| 国产成人精品视频免费 | 午夜丁香婷婷 | 国产成人精品视频免费 | 中文字幕第一页亚洲 | www成人免费视频 | 91麻豆精品久久久久蜜臀 | 激情综合五月婷婷 | 超污网站在线观看 | av网站亚洲 | 99精品小视频 | 四虎永久免费 | 在线播放国产精品 | 久久久久久久久久av | 婷婷色中文网 | 久久99久久99精品免视看婷婷 | 亚洲美女免费视频 | 国产精品成人免费精品自在线观看 | 欧美一区二区三区激情视频 | 日韩在线观看第一页 | 国产免费黄色片 | 免费的av片 | 麻豆国产原创 | 亚洲自拍偷拍综合 | 九色影院 | 国产精品久久久网站 | 中文精品视频 | 93看片淫黄大片一级 | 欧美视频在线一区 | 欧美三级在线看 | 欧美激情黑白配 | chinesemature高潮| 青青草成人在线 | 亚洲成人一区二区 | 黄色网址视频在线观看 | 日韩在线视频免费 | 夜夜春视频 | 在线视频亚洲 | av在线首页 | 亚洲国产精品久 |